包裹性结核性胸腔积液临床治疗体会

The encapsulated tuberculous pleural effusion clinical treatment experience

目的：探讨包裹性结核性胸腔积液的临床治疗措施。方法：选取我院自2008年6月至2011年6月收治的包裹性结核性胸腔积液患者共计148例，将其分为观察组与对照组，每组74例，均进行抽液注药（异烟肼、地塞米松）治疗，观察组加用尿激酶治疗。对两组患者的治疗效果进行对比分析。结果：观察组患者结核中毒症状减轻，胸腔积液明显减少，治疗有效率高，各指标均明显优于对照组，其差并有统计学意义（P〈0．05）。结论：包裹性结核性胸腔积液应用抗结核药物治疗同时，加用尿激酶，能够显著减少胸腔积液量，减轻胸膜肥厚、粘连，本疗法简单易行，疗效可靠，应大力推广应用。

Objective：To investigate the encapsulated tuberculous pleural effusion clinical treatment measures. Methods：in our hospital from 2008 June to 2011 June were encapsulated tuberculous pleural effusion in a patient with a total of 148 patients,divided into the observation group and con- trol group, 74 cases in each group, both drainage and drug injection （isoniazid, dexamethasone treatment, the observation group） with urokinase in the treatment of. Two groups of patients with treatment effect comparative analysis. Results in the observation group tubercular toxic symptom relief, pleural effusion was significantly reduced, the treatment efficiency is high, the indicators are significantly better than the control group, the difference was statistically significant （P〈0. 05）. Conclusion：The encapsulated tuberculous pleural effusion of antituberculosis drug treatment at the same time, combined with urokinase,can signifieantiy reduce the amount of pleural effusion, pieural thickening, adhesion reduction, this therapy is simple and easy to operate, reliable curative effect, should popularize application energetically.